Fda revokes emergency use authorization for chembio antibody test

Fda says revokes emergency use authorization for chembio antibody test.fda - revoked eua of chembio system dpp covid-19 igm/igg system, a sars-cov-2 antibody test, due to performance concerns with accuracy of test.
CEMI Ratings Summary
CEMI Quant Ranking